UTMD

Utah Medical Products INC

+$22.9M

Net Activity

Institutions Holding

120

Popularity Rank

#4081

Avg Weight

0.04%

Total Value

$140.4M

Ownership Trend

120 institutions currently hold UTMD, with 57 net buyers and 39 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Majority Increased

Based on recent trading activity

Net Selling Institutions

39

Net Buying Institutions

57

Key Holders

View all 120 holding institutions

Quarterly Activity

Recent Activity

+$91.9M

Total Buy Value

$33.5M

Total Sell Value

New buy9
Trim30
Add48
Sold out9

57

Net Buyers

39

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding UTAH MEDICAL PRODUCTS INC (UTMD)?
Major stakeholders currently include Brandes Investment Partners, LP ($27.9M), Dimensional Fund Advisors LP ($12.3M), BlackRock, Inc. ($11.6M). Based on the latest 13F filings, there are a total of 120 tracked investment funds and institutions maintaining positions in UTMD.
What is the overall institutional sentiment toward UTMD recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $22.9M, driven by 57 managers accumulating shares while 39 reduced their exposure.
Which institutions have been selling or reducing their UTMD positions?
In the latest period, 30 funds trimmed their holdings, and 9 managers completely exited their positions. The aggregate reported sell value was $33.5M.
Are there any notable investors adding UTMD to their portfolios?
Yes, buying activity remains notable. 9 institutions opened new positions in {ticker}, and 48 existing holders added to their shares. The total reported buy value for the quarter amounted to $91.9M.

Related Stocks